Preventing Futile Liver Resection: A Risk-Based Approach to Surgical Selection in Major Hepatectomy for Colorectal Cancer

[1]  Yanming Zhou,et al.  Survival after repeat hepatectomy for recurrent colorectal liver metastasis: A review and meta-analysis of prognostic factors. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

[2]  K. Kichikawa,et al.  Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study , 2019, BMC Cancer.

[3]  Jason D. Wright,et al.  FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data. , 2019, Clinical colorectal cancer.

[4]  A. Sugioka,et al.  Repeat hepatectomy with systemic chemotherapy might improve survival of recurrent liver metastasis from colorectal cancer—a retrospective observational study , 2019, World Journal of Surgical Oncology.

[5]  B. Xing,et al.  Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis , 2018, World Journal of Surgical Oncology.

[6]  B. Gayet,et al.  Laparoscopic versus open major hepatectomy: a systematic review and meta‐analysis of individual patient data , 2018, Surgery.

[7]  Z. Pan,et al.  Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis , 2017, Journal of Cancer Research and Clinical Oncology.

[8]  T. Gruenberger,et al.  Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients. , 2017, European journal of cancer.

[9]  J. Gaughan,et al.  The utility of the MELD score in predicting mortality following liver resection for metastasis. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  H. Bismuth,et al.  Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors? , 2016, The oncologist.

[11]  T. Crocenzi,et al.  Randomized controlled trial of irinotecan drug‐eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver‐limited metastasis , 2015, Cancer.

[12]  R. Bhogal,et al.  Predictors of early recurrence after resection of colorectal liver metastases , 2015, World Journal of Surgical Oncology.

[13]  M. Gerken,et al.  Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma , 2014, BMC Cancer.

[14]  K. Brown,et al.  Trends in Treatment and Survival in Older Patients Presenting with Stage IV Colorectal Cancer , 2014, Journal of Gastrointestinal Surgery.

[15]  M. Gonen,et al.  Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[16]  R. J. Haas,et al.  Repeat hepatectomy for recurrent colorectal metastases , 2013, The British journal of surgery.

[17]  T. Yoshino,et al.  Predictors for Early Recurrence After Hepatectomy for Initially Unresectable Colorectal Liver Metastasis , 2013, Journal of Gastrointestinal Surgery.

[18]  A. Kwon,et al.  Predictors and outcome of early recurrence after resection of hepatic metastases from colorectal cancer , 2012, Langenbeck's Archives of Surgery.

[19]  T. Chua,et al.  Predictors of cure after hepatic resection of colorectal liver metastases: An analysis of actual 5‐ and 10‐year survivors , 2011, Journal of surgical oncology.

[20]  R. Parks,et al.  What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[21]  H. Malik,et al.  Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  G. Cooper,et al.  Survival after hepatic resection in metastatic colorectal cancer , 2007, Cancer.

[23]  C. Lepage,et al.  Epidemiology and Management of Liver Metastases From Colorectal Cancer , 2006, Annals of surgery.

[24]  T. Kinoshitá,et al.  Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. , 2006, Japanese journal of clinical oncology.

[25]  G. Sugawara,et al.  Repeat Hepatectomy for Recurrent Colorectal Metastases , 2005, Surgery Today.

[26]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[27]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[28]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[29]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[30]  K. McMasters,et al.  Recurrence Following Hepatectomy for Metastatic Colorectal Cancer: Development of a Model that Predicts Patterns of Recurrence and Survival , 2011, Annals of Surgical Oncology.

[31]  F. Lévi,et al.  Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.